Lung cancer Cancer Malignant neoplasm of bronchus and lung
Conditions
Interventions
Members of the public presenting at community pharmacies with symptoms of lung cancer will be offered a consultation with the pharmacist and if required, direct referral to the local hospital for a ch
Sponsors
Hywel Dda University Health Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals over the age of 40, who are current or ex-smokers with a history of 10 or more smoking pack-years, and have had 1 or more of the following, for more than three weeks: 1.1. Coughing up blood 1.2. High pitched audible wheeze 1.3. Neck vein engorgement/facial swelling 1.4. Cough 1.5. Chest and/or shoulder pain 1.6. Unexplained weight loss 1.7. Shortness of breath 1.8. Hoarse voice 1.9. Finger clubbing 1.10. Swollen nodes in the head or neck 2. Community pharmacists and respiratory physicians involved in patient care
Exclusion criteria
Exclusion criteria: 1. Unable or unwilling to provide written informed consent 2. Patients who have a diagnosed cognitive impairment will be excluded from the evaluation/ follow up element of the study 3. WHO performance status 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Number of patients referred via the pathway measured using case report forms at the end of the study 2. Number of patients referred with a lung cancer diagnosis measured using patient records at the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessed using a novel questionnaire and interview at a single time point: 1. Acceptability of the pathway to patients and healthcare professionals 2. Perceived impact on pharmacy workload and radiology referrals 3. Patient and professional views and experiences of consulting the pharmacist | — |
Countries
United Kingdom, Wales
Contacts
Public ContactSarah Rees
Outcome results
None listed